{
    "title": "Gilead Sciences reports almost $900 mn in Q3 remdesivir sales",
    "url": "https://www.dailymail.co.uk/wires/afp/article-8890721/Gilead-Sciences-reports-900-mn-Q3-remdesivir-sales.html",
    "date": "2020-10-28",
    "keywords": [
        "gilead",
        "remdesivir",
        "covid19",
        "jump",
        "thirdquarter",
        "treatment",
        "company",
        "coronavirus",
        "percent",
        "drug",
        "part",
        "drugmaker",
        "medication",
        "brand",
        "name",
        "veklury",
        "ebola",
        "recovery",
        "time",
        "profit",
        "loss",
        "period",
        "food",
        "administration",
        "approval",
        "authorization",
        "injection",
        "promise",
        "virus",
        "efficacy",
        "mortality",
        "rate",
        "president",
        "october",
        "hospital"
    ],
    "category": [
        "wires",
        "afp"
    ]
}